Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Dose-response Study of the Efficacy and Safety of MEDI7352 in Subjects With Painful Osteoarthritis of the Knee

NCT04675034 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04675034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04675034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Dose-response Study of the Efficacy and Safety of MEDI7352 in Subjects With Painful Osteoarthritis of the Knee
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
December 2, 2020
Completion date
August 16, 2023
Enrollment
345 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

painful osteoarthritis of the knee